LY 404187,新型AMPA受体阳性变构调节剂
|
L274875-1mg
|
Moligand™, ≥98% |
211311-95-4 |
1mg
|
¥ 411.9
|
期货,请咨询 |
阿拉丁 |
LY 404187,新型AMPA受体阳性变构调节剂
|
L274875-100mg
|
Moligand™, ≥98% |
211311-95-4 |
100mg
|
¥ 5973.9
|
期货,请咨询 |
阿拉丁 |
5-溴-2-氯-3-(三氟甲基)吡啶
|
B182739-100g
|
≥97% |
211122-40-6 |
100g
|
¥ 1520.9
|
现货 |
阿拉丁 |
JNJ-63576253 HCl
|
J419996-5mg
|
≥98% |
2110428-64-1 |
5mg
|
¥ 718.9
|
现货 |
阿拉丁 |
JNJ-63576253 HCl
|
J419996-25mg
|
≥98% |
2110428-64-1 |
25mg
|
¥ 2409.9
|
现货 |
阿拉丁 |
JNJ-63576253 HCl
|
J419996-100mg
|
≥98% |
2110428-64-1 |
100mg
|
¥ 4633.9
|
现货 |
阿拉丁 |
3-氨基苯硼酸频呐醇酯
|
A119987-100g
|
≥97% |
210907-84-9 |
100g
|
¥ 1299.9
|
现货 |
阿拉丁 |
MCC950
|
M414276-50mg
|
Moligand™, ≥97% |
210826-40-7 |
50mg
|
¥ 2399.9
|
现货 |
阿拉丁 |
MCC950
|
M414276-10mg
|
Moligand™, ≥97% |
210826-40-7 |
10mg
|
¥ 679.9
|
现货 |
阿拉丁 |
MCC950
|
M414276-100mg
|
Moligand™, ≥97% |
210826-40-7 |
100mg
|
¥ 3799.9
|
现货 |
阿拉丁 |
苔黑酚葡萄糖苷
|
S138473-50mg
|
≥98% |
21082-33-7 |
50mg
|
¥ 617.9
|
现货 |
阿拉丁 |
苔黑酚葡萄糖苷
|
S138473-500mg
|
≥98% |
21082-33-7 |
500mg
|
¥ 2779.9
|
现货 |
阿拉丁 |
苔黑酚葡萄糖苷
|
S138473-10mg
|
≥98% |
21082-33-7 |
10mg
|
¥ 205.9
|
现货 |
阿拉丁 |
苔黑酚葡萄糖苷
|
S138473-100mg
|
≥98% |
21082-33-7 |
100mg
|
¥ 766.9
|
现货 |
阿拉丁 |
3-噻吩丙二酸
|
T124059-500g
|
≥98% |
21080-92-2 |
500g
|
¥ 2329.9
|
现货 |
阿拉丁 |
Z-DEVD-FMK,caspase-3抑制剂
|
Z302772-10mg
|
≥98% |
210344-95-9 |
10mg
|
¥ 1619.9
|
现货 |
阿拉丁 |
HA-100二盐酸盐
|
H412832-50mg
|
≥98% |
210297-47-5 |
50mg
|
¥ 5870.9
|
现货 |
阿拉丁 |
HA-100二盐酸盐
|
H412832-10mg
|
≥98% |
210297-47-5 |
10mg
|
¥ 1203.9
|
现货 |
阿拉丁 |
HA-100二盐酸盐
|
H412832-100mg
|
≥98% |
210297-47-5 |
100mg
|
¥ 8341.9
|
现货 |
阿拉丁 |
柠檬酸卡考尼碱(MLA)
|
M275613-10mM-ml
|
Moligand™, ≥98% |
21019-30-7 |
10mM/ml
|
¥ 870.9
|
期货,请咨询 |
阿拉丁 |
BL-918
|
B412568-50mg
|
≥99% |
2101517-69-3 |
50mg
|
¥ 6385.9
|
现货 |
阿拉丁 |
BL-918
|
B412568-10mg
|
≥99% |
2101517-69-3 |
10mg
|
¥ 1807.9
|
现货 |
阿拉丁 |
Gboxin
|
G414204-50mg
|
≥99% |
2101315-36-8 |
50mg
|
¥ 7499.9
|
现货 |
阿拉丁 |
Gboxin
|
G414204-25mg
|
≥99% |
2101315-36-8 |
25mg
|
¥ 5013.9
|
现货 |
阿拉丁 |